Hendley & CO Inc Bristol Myers Squibb CO Transaction History

Hendley & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $2.08 Million - $2.35 Million	-35,967 Closed	0 $0
Q3 2020 Oct 21, 2020	SELL	$57.43 - $63.64 $76,669 - $84,959	-1,335 Reduced 3.58%	35,967 $2.17 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $80,037 - $93,571	-1,460 Reduced 3.77%	37,302 $2.19 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $25,056 - $36,412	540 Added 1.41%	38,762 $2.16 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $1.88 Million - $2.45 Million	38,222 New	38,222 $2.45 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Hendley & CO Inc with notifications on news.